Skip to main content
SpringerLink
Log in

Systemic Small Vessel Vasculitis

  • Chapter
  • First Online:
Practical Nephrology

  • 2432 Accesses

Abstract

The vasculitides are inflammatory disorders of blood vessels that can be classified as primary or secondary and as localised or systemic. Localised vasculitis affects a single organ, such as the skin, whereas the systemic vasculitides affect multiple organ systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jennette JC, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–92.

    Article  CAS  PubMed  Google Scholar 

  2. Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135–6.

    Article  CAS  PubMed  Google Scholar 

  3. Watts R, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7.

    PubMed Central  PubMed  Google Scholar 

  4. Lane SE, et al. Primary systemic vasculitis: clinical features and mortality. QJM. 2005;98(2):97–111.

    Article  CAS  PubMed  Google Scholar 

  5. Watts RA, et al. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43(2):414–9.

    Article  CAS  PubMed  Google Scholar 

  6. Aries PM, et al. No seasonal variation in the onset of symptoms of 445 patients with Wegener’s granulomatosis. Arthritis Rheum. 2008;59(6):904.

    Article  CAS  PubMed  Google Scholar 

  7. Little MA, et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis. 2010;69(6):1036–43.

    Article  PubMed  Google Scholar 

  8. Savige J, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;111(4):507–13.

    CAS  PubMed  Google Scholar 

  9. Hagen EC, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53(3):743–53.

    Article  CAS  PubMed  Google Scholar 

  10. Beaudreuil S, et al. Occupational exposure in ANCA-positive patients: a case–control study. Kidney Int. 2005;67(5):1961–6.

    Article  PubMed  Google Scholar 

  11. Hogan SL, et al. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol. 2001;12(1):134–42.

    CAS  PubMed  Google Scholar 

  12. Leigh J, et al. Silica-induced apoptosis in alveolar and granulomatous cells in vivo. Environ Health Perspect. 1997;105 Suppl 5:1241–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Chen M, Kallenberg CG. ANCA-associated vasculitides – advances in pathogenesis and treatment. Nat Rev Rheumatol. 2010;6(11):653–64.

    Article  CAS  PubMed  Google Scholar 

  14. Stegeman CA, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994;120(1):12–7.

    Article  CAS  PubMed  Google Scholar 

  15. Stegeman CA, et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996;335(1):16–20.

    Article  CAS  PubMed  Google Scholar 

  16. Pendergraft 3rd WF, et al. Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10(1):72–9.

    Article  CAS  PubMed  Google Scholar 

  17. Tadema H, et al. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One. 2011;6(3):e17972.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Kallenberg CG, Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to “autoimmunity and infection”. Autoimmun Rev. 2008;8(1):29–32.

    Article  PubMed  Google Scholar 

  19. Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol. 2004;93(4):398–401.

    Article  PubMed  Google Scholar 

  20. Boomsma MM, et al. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 2000;43(9):2025–33.

    Article  CAS  PubMed  Google Scholar 

  21. Birck R, et al. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis. 2006;47(1):15–23.

    Article  PubMed  Google Scholar 

  22. Kerr GS, et al. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum. 1993;36(3):365–71.

    Article  CAS  PubMed  Google Scholar 

  23. Stegeman CA. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol Dial Transplant. 2002;17(12):2077–80.

    Article  CAS  PubMed  Google Scholar 

  24. Stone JH, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. de Groot K, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670–80.

    Article  PubMed  Google Scholar 

  26. Harper L, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012;71:955–60.

    Article  CAS  PubMed  Google Scholar 

  27. Jayne DR, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180–8.

    Article  CAS  PubMed  Google Scholar 

  28. de Lind van Wijngaarden RA, et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2007;18(7):2189–97.

    Article  Google Scholar 

  29. De Groot K, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461–9.

    Article  PubMed  Google Scholar 

  30. Jayne D, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  31. Pagnoux C, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790–803.

    Article  CAS  PubMed  Google Scholar 

  32. Hiemstra TF, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21):2381–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imperial Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK

    Tabitha Turner-Stokes MA (cantab), MBBS

  2. Trinity Health Kidney Centre, Tallaght Hospital and Trinity College Dublin, Tallaght, Dublin 24, Ireland

    Mark A. Little FRCP, PhD

Authors
  1. Tabitha Turner-Stokes MA (cantab), MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Little FRCP, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tabitha Turner-Stokes MA (cantab), MBBS .

Editor information

Editors and Affiliations

  1. UCL Department of Nephrology, Royal Free London NHS Foundation Trust, London, United Kingdom

    Mark Harber

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Turner-Stokes, T., Little, M.A. (2014). Systemic Small Vessel Vasculitis. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5547-8_20

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5546-1

  • Online ISBN: 978-1-4471-5547-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation